Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2025 value amounting to $330,000.

  • Benitec Biopharma's Amortizatization of Intangibles rose 60.00% to $104,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $330,000, marking a year-over-year increase of 28.91%. This contributed to the annual value of $330,000 for FY2025, which is 28.91% up from last year.
  • According to the latest figures from FY2025, Benitec Biopharma's Amortizatization of Intangibles is $330,000, which was up 28.91% from $256,000 recorded in FY2024.
  • Benitec Biopharma's Amortizatization of Intangibles' 5-year high stood at $330,000 during FY2025, with a 5-year trough of $193,000 in FY2021.
  • In the last 3 years, Benitec Biopharma's Amortizatization of Intangibles had a median value of $256,000 in 2024 and averaged $277,000.
  • Data for Benitec Biopharma's Amortizatization of Intangibles shows a peak YoY grew of 28.91% (in 2025) over the last 5 years.
  • Yearly analysis of 5 years shows Benitec Biopharma's Amortizatization of Intangibles stood at $193,000 in 2021, then rose by 16.58% to $225,000 in 2022, then increased by 8.89% to $245,000 in 2023, then increased by 4.49% to $256,000 in 2024, then climbed by 28.91% to $330,000 in 2025.